.Kailera Rehabs has released in to the considerably packed excessive weight area along with a profil...
.Along with very early phase 1 records right now out in the wild, metabolic illness outfit Metsera i...
.Rivus Pharmaceuticals has revealed the records responsible for its period 2 weight problems gain in...
.Bristol Myers Squibb is paying Main Medication $110 million in advance to cultivate reagents for ex...
.Novartis has tattooed a package likely worth greater than $1 billion with Flagship-founded Generate...
.Just recently debuted Metsera is unfolding some stage 1 data for its own GLP-1 receptor agonist, re...
.In the middle of the genetic medications branches race, Main Pioneering is introducing a brand new ...
.BioAge Labs is actually looking at around $180 million in preliminary earnings from an IPO and also...
.An effort through Merck & Co. to open the microsatellite secure (MSS) metastatic colorectal canc...
.Spain-based Asabys Partners has shut a fund of 180 thousand euros ($ 200 million), loan that will g...